This leads to lower energy levels
"BPC" stands for "Body Protection Compound." In preclinical work it is proposed to act through several overlapping pathways, including promotion of new blood-vessel growth (angiogenesis), modulation of nitric-oxide signaling, and anti-inflammatory activity, rather than through one well-defined receptor mechanism the way a conventional small-molecule drug does
Yang et al., 2014)
doi:10.1056/NEJMoa2302392 Ukhanova M, Wozny JS, Truong CN, Ghosh L, Krause TM
Potential Roadblocks and Delays What Could Slow Approval Safety Signals (624 months): Unexpected serious adverse events identified during FDA review requiring additional data collection
Wegovy comes in additional higher dosage strengths of 1.7 mg, 2.4 mg, and 7.2 mg, which take time to ramp up to